Literature DB >> 10908767

Endoglin expression as a measure of microvessel density in cervical cancer.

C A Brewer1, J J Setterdahl, M J Li, J M Johnston, J L Mann, M E McAsey.   

Abstract

OBJECTIVE: To evaluate endoglin, a membrane protein and member of the transforming growth factor beta-1 receptor complex, as an endothelial marker of angiogenesis in cervical cancer tissues.
METHODS: Tumor tissue was collected from 31 surgically treated stage IB nonbulky (under 5 cm) cervical cancer subjects, and samples were fixed in formalin and embedded in paraffin. Endoglin was stained on 5-microm slide sections by the DAKO Catalyzed Signal Amplification method (DAKO Corporation, Carpinteria, CA). Factor VIII was stained by standard immunohistochemistry. Positively stained microvessels were counted in "hot spots" at 200x magnification. Clinical data were correlated with vessel counts by Spearman correlation. Mean differences in counts were tested using paired t tests.
RESULTS: This staining method for endoglin identified significantly more vessels than the factor VIII method (mean 92 +/- 45 versus 33 +/- 16, P <. 001). Endoglin and factor VIII counts correlated significantly with deep stromal invasion (Spearman rho 0.466 and 0.522, respectively, P <.05); however, only endoglin counts correlated significantly with lymph node metastases (rho =.495, P <.01).
CONCLUSION: Endoglin is stimulated in tumor angiogenesis and might be relatively more specific than commonly used endothelial markers. The endoglin system was more sensitive for staining capillaries in neoplastic cervical tissue, better predicted lymph node metastases, and should be widely applicable for the study of other tumors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908767     DOI: 10.1016/s0029-7844(00)00864-4

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  17 in total

1.  Endoglin promotes TGF-β/Smad1 signaling in scleroderma fibroblasts.

Authors:  Erin Morris; Izabela Chrobak; Andreea Bujor; Faye Hant; Christine Mummery; Peter Ten Dijke; Maria Trojanowska
Journal:  J Cell Physiol       Date:  2011-12       Impact factor: 6.384

2.  Endoglin (CD105) expression in angiogenesis of colon cancer: analysis using tissue microarrays and comparison with other endothelial markers.

Authors:  Rahmawati Minhajat; Daisuke Mori; Fumio Yamasaki; Yasuo Sugita; Toshimi Satoh; Osamu Tokunaga
Journal:  Virchows Arch       Date:  2005-09-22       Impact factor: 4.064

3.  Vascular endothelial growth factor and endoglin (CD-105) in gastric cancer.

Authors:  Nikolaos I Nikiteas; Nikolaos Tzanakis; George Theodoropoulos; Vassilios Atsaves; Zoi Christoni; Petros Karakitsos; Andreas C Lazaris; Antonis Papachristodoulou; Christos Klonaris; Maria Gazouli
Journal:  Gastric Cancer       Date:  2007-02-23       Impact factor: 7.370

4.  Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma.

Authors:  Panayiotis A Kyzas; Niki J Agnantis; Dimitrios Stefanou
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

5.  Tgf-Beta superfamily receptors-targets for antiangiogenic therapy?

Authors:  Jasmin Otten; Carsten Bokemeyer; Walter Fiedler
Journal:  J Oncol       Date:  2010-05-13       Impact factor: 4.375

6.  Immunoexpression of endoglin in brain metastasis secondary to malignant melanoma: evaluation of angiogenesis and comparison with brain metastasis secondary to breast and lung carcinomas.

Authors:  Karina B Salgado; Nadima V Toscani; Leonardo L M Silva; Arlete Hilbig; Ligia Maria Barbosa-Coutinho
Journal:  Clin Exp Metastasis       Date:  2007-06-13       Impact factor: 5.150

7.  Markers of angiogenesis in high-risk, early-stage cervical cancer: A Gynecologic Oncology Group study.

Authors:  Leslie M Randall; Bradley J Monk; Kathleen M Darcy; Chunqiao Tian; Robert A Burger; Shu-Yuan Liao; William A Peters; Richard J Stock; John P Fruehauf
Journal:  Gynecol Oncol       Date:  2008-12-24       Impact factor: 5.482

8.  Both high intratumoral microvessel density determined using CD105 antibody and elevated plasma levels of CD105 in colorectal cancer patients correlate with poor prognosis.

Authors:  C Li; R Gardy; B K Seon; S E Duff; S Abdalla; A Renehan; S T O'Dwyer; N Haboubi; S Kumar
Journal:  Br J Cancer       Date:  2003-05-06       Impact factor: 7.640

9.  Tumor vascular homing endgolin-targeted radioimmunotherapy in hepatocellular carcinoma.

Authors:  Chong-Ling Duan; Gui-Hua Hou; Yan-Ping Liu; Ting Liang; Jing Song; Jian-Kui Han; Chao Zhang
Journal:  Tumour Biol       Date:  2014-08-28

10.  SPARC-induced increase in glioma matrix and decrease in vascularity are associated with reduced VEGF expression and secretion.

Authors:  Christopher K Yunker; William Golembieski; Nancy Lemke; Chad R Schultz; Simona Cazacu; Chaya Brodie; Sandra A Rempel
Journal:  Int J Cancer       Date:  2008-06-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.